| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 33.3% | 6/18 |
| Female | 66.7% | 12/18 |
| Indifferent | 0% | 0/18 |
| Unknown | 0% | 0/18 |
| General | ||
| 16.7% | 3/18 | |
| 38.9% | 7/18 | |
| 33.3% | 6/18 | |
| 38.9% | 7/18 | |
| 38.9% | 7/18 | |
| 88.9% | 16/18 | |
| 66.7% | 12/18 | |
| 83.3% | 15/18 | |
| 66.7% | 12/18 | |
| 91.7% | 11/12 | |
| Neurology | ||
| 33.3% | 6/18 | |
| 44.4% | 8/18 | |
| 38.9% | 7/18 | |
| Facial abnormalities | ||
| 27.8% | 5/18 | |
| 88.9% | 16/18 | |
| 94.4% | 17/18 | |
| 100% | 18/18 | |
| Visual and hearing impairments | ||
| 16.7% | 3/18 | |
| 33.3% | 6/18 | |
| Heart | ||
| 44.4% | 8/18 | |
| Pulmonary | ||
| 5.6% | 1/18 | |
| Gastrointestinal | ||
| 44.4% | 8/18 | |
| Urogenital | ||
| 66.7% | 12/18 | |
| Skeleton | ||
| 50% | 9/18 | |
| Skin / Hair / Nails | ||
| 61.1% | 11/18 | |
| Endocrine / Immunological / Metabolic | ||
| 11.1% | 2/18 | |
| Metabolic | 0% | 0/18 |
| 27.8% | 5/18 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/18 |
| Inheritance | ||
| 100% | 18/18 | |
THOC6